Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2014
09/23/2014US8841309 Substituted pyrazines and their use in the treatment of disease
09/23/2014US8841304 Pyrrolopyridines as kinase inhibitors
09/23/2014US8841298 Substituted pyrano[2,3-B]pyrazines as herbicides
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841289 Heterocyclic derivatives
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/23/2014US8841067 NOL3 is a predictor of patient outcome
09/23/2014US8841004 Binaphthyl compound and organic light emitting element using the same
09/23/2014CA2758019C Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
09/23/2014CA2629738C Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
09/23/2014CA2608977C Antifungal agents
09/18/2014WO2014145857A1 TARGETING THE mTOR PATHWAY IN NEUROLOGICAL DISEASE
09/18/2014WO2014145051A1 Heterocyclic compounds and uses thereof
09/18/2014WO2014144984A1 Compositions with thixotropy and enhanced dissolution reproducibility and stability
09/18/2014WO2014144747A1 Substituted 6,5-fused bicyclic heteroaryl compounds
09/18/2014WO2014144455A1 1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014143915A1 Novel crystalline forms
09/18/2014WO2014143768A1 Tricyclic heterocycles as bet protein inhibitors
09/18/2014WO2014143672A1 Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
09/18/2014WO2014143638A1 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
09/18/2014WO2014143583A1 Imidazo pyridine compounds
09/18/2014WO2014143240A1 Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
09/18/2014WO2014142488A1 Organic compound and organic electroluminescent element including same
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014141132A1 NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
09/18/2014WO2014141118A1 Imidazo[4,5-c]quinoline derivatives and uses thereof
09/18/2014WO2014140592A1 Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as ssao inhibitors
09/18/2014WO2014140591A1 New compounds
09/18/2014WO2014140365A1 Microbicidally active imidazopyridine derivatives
09/18/2014WO2014140318A1 Improved process for acyl transfer reactions
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014WO2014140184A1 Novel inhibitor compounds of phosphodiesterase type 10a
09/18/2014WO2014140078A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140075A1 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140065A1 N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals
09/18/2014WO2014139978A1 New octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
09/18/2014WO2014139882A1 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
09/18/2014WO2014139681A1 Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1h]-pyrido[3,4-b]indol]-4-amine
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014WO2014139388A1 Novel indole derivatives useful as anti-diabetic agents
09/18/2014WO2014139328A1 Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
09/18/2014WO2014138791A1 Transgenic non-human organisms with non-functional tspo genes
09/18/2014US20140275548 Substituted naphthyridine and quinoline compounds as mao inhibitors
09/18/2014US20140275547 Stable sns-595 compositions and methods of preparation
09/18/2014US20140275546 Azaadamantane formate ester and process for preparing azaadamantane derivatives
09/18/2014US20140275540 Processes For The Preparation Of An Apoptosis-Inducing Agent
09/18/2014US20140275527 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/18/2014US20140275153 Cdk9 kinase inhibitors
09/18/2014US20140275152 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275130 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275120 P2x7 modulators
09/18/2014US20140275108 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/2014US20140275086 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014US20140275082 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/18/2014US20140275065 Substituted 7-azabicyles and their use as orexin receptor modulators
09/18/2014US20140275063 New enzyme inhibitor compounds
09/18/2014US20140275062 Diimide compounds
09/18/2014US20140275061 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
09/18/2014US20140275058 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/18/2014US20140275056 P2x7 modulators
09/18/2014US20140275055 Protein Kinase C Inhibitors and Uses Thereof
09/18/2014US20140275042 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems
09/18/2014US20140275040 New compounds
09/18/2014US20140275033 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
09/18/2014US20140275030 Tricyclic heterocycles as bet protein inhibitors
09/18/2014US20140275027 Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
09/18/2014US20140275026 Dihydro-pyrrolopyridinone inhibitors
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275023 Substituted Tricyclic Pyrazolo-Pyrimidine Compounds
09/18/2014US20140275020 Inhibitors of the renal outer medullary potassium channel
09/18/2014US20140275019 Tetrahydropyridine derivatives as fabi inhibitors
09/18/2014US20140275018 Nitrogen containing compounds
09/18/2014US20140275017 Cgrp receptor antagonists
09/18/2014US20140275015 P2x7 modulators
09/18/2014US20140275013 Compounds and compositions for the treatment of parasitic diseases
09/18/2014US20140275009 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275006 Azole derivative
09/18/2014US20140275005 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
09/18/2014US20140275001 Crystalline form of a beta-lactamase inhibitor
09/18/2014US20140274926 Compounds and compositions for the treatment of parasitic diseases
09/17/2014EP2778161A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof
09/17/2014EP2778160A1 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2776519A1 Polymer-bonded polycyclic aromatic hydrocarbons having nitrogen containing substituents
09/17/2014EP2776437A1 Modulators of opioid receptors and methods of use thereof
09/17/2014EP2776436A1 New compounds
09/17/2014EP2776435A1 Anticancer pyridopyrazines via the inhibition of fgfr kinases
09/17/2014EP2776434A1 Pyridopyrimidinone inhibitors of kinases
09/17/2014EP2776418A1 Inhibitors of phosphodiesterase type 10a
09/17/2014EP2776416A1 Pharmaceutical compounds
09/17/2014EP2776405A1 2-thiopyrimidinones
09/17/2014EP2776396A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776070A1 Immunomodulatory conjugates
09/17/2014EP2776027A1 Nadph oxidase 4 inhibitors and use thereof
09/16/2014US8835648 Hedgehog pathway antagonists and therapeutic applications thereof
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 646